Lets take a look at AMED ($25.11). As recently as April 14th, AMED was trading above 64.00 per share. Since that time, there has been some negative news on the stock, including a class-action lawsuit1, an SEC investigation2 an earnings miss3 and overall weakness in the home healthcare industry.